Ingredient is not a complete description
Semaglutide is a GLP-1 receptor agonist. The exact branded product, route and labeled use matter. A quoted ingredient alone does not establish what you would receive.
Approved and compounded are different
Compounded semaglutide is not FDA-approved. It does not have the same premarket review as an approved product. Ask why a compounded preparation is being proposed and which licensed pharmacy is responsible.
How to compare two offers
Put the formulation, supply period, care membership and pharmacy charge side by side. Keep an insurance estimate separate from a confirmed cash price. Your prescriber should handle questions about suitability and treatment changes.
A practical next step
Use the provider directory to explore services, then request a product-specific written quote. Do not use a low starting price as a reason to skip the clinical evaluation.
Further reading
Clinical and regulatory context: FDA concerns with unapproved GLP-1 drugs. Service-cost examples use provider sources checked October 12, 2026. No clinical review is claimed.